Autolus Therapeutics (AUTL) Other Non Operating Income (2017 - 2025)
Historic Other Non Operating Income for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$911000.0.
- Autolus Therapeutics' Other Non Operating Income rose 9234.45% to -$911000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 24779.25%. This contributed to the annual value of -$1.0 million for FY2024, which is 13789.31% down from last year.
- Latest data reveals that Autolus Therapeutics reported Other Non Operating Income of -$911000.0 as of Q3 2025, which was up 9234.45% from $1.5 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Other Non Operating Income ranged from a high of $951.0 million in Q3 2021 and a low of -$11.9 million during Q3 2024
- In the last 5 years, Autolus Therapeutics' Other Non Operating Income had a median value of $782000.0 in 2023 and averaged $50.3 million.
- Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 3800354.72% in 2021, then crashed by 58667.05% in 2024.
- Over the past 5 years, Autolus Therapeutics' Other Non Operating Income (Quarter) stood at -$86000.0 in 2021, then skyrocketed by 7369.77% to $6.3 million in 2022, then plummeted by 50.72% to $3.1 million in 2023, then soared by 270.01% to $11.4 million in 2024, then tumbled by 107.99% to -$911000.0 in 2025.
- Its Other Non Operating Income was -$911000.0 in Q3 2025, compared to $1.5 million in Q2 2025 and $1.2 million in Q1 2025.